4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Guangbo Fu, Jialin Tang, Meilin Wang, Chao Qin, Fu Yan, Qi Ding, Changjun Yin, Xinru Wang, Zhengdong Zhang. CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men[J]. The Journal of Biomedical Research, 2011, 25(2): 128-134. DOI: 10.1016/S1674-8301(11)60016-X
Citation: Guangbo Fu, Jialin Tang, Meilin Wang, Chao Qin, Fu Yan, Qi Ding, Changjun Yin, Xinru Wang, Zhengdong Zhang. CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men[J]. The Journal of Biomedical Research, 2011, 25(2): 128-134. DOI: 10.1016/S1674-8301(11)60016-X

CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men

Funds: 

This study was partly supported by National Natural Science Foun-dation of China (No. 30872084 and No. 30972444), the Key Program for Basic Research of Jiangsu Provincial Department of Education (No. 08KJA330001) and "Qinglan Project" Foundation for the Y

More Information
  • Caspase-8 (CASP8) plays a key role in apoptosis. We examined by genotyping whether the -652 six-nucleotide insertion-deletion (6N ins/del) polymorphism in the CASP8 promoter region associated with prostate cancer risk in a hospital-based cohort of 406 Chinese prostate cancer patients and 408 age-matched cancer-free controls. Additionally,23 prostate cancer tissues were analyzed for CASP8 mRNA expression. We found a significantly decreased prostate cancer risk for the 6N ins/del genotype [adjusted odds ratio (OR)=0.68; 95% confidence interval (CI)=0.51-0.92] and del/del genotype (OR=0.34; 95% CI=0.19-0.63) compared with the ins/ins genotype. The 6N del allele was associated dose-dependently with decreased prostate cancer risk (Ptrend = 0.001). RT-PCR showed that individuals with the 6N del allele had lower CASP8 mRNA levels than those with the ins/ins genotype (P =0.024). These findings suggested that the CASP8 -652 6N ins/del polymorphism may affect the susceptibility to prostate cancer and reduce prostate cancer risk among Chinese men.
  • Related Articles

    [1]Yifei Cheng, Rongjie Shi, Shuai Ben, Silu Chen, Shuwei Li, Junyi Xin, Meilin Wang, Gong Cheng. Genetic variation of circHIBADH enhances prostate cancer risk through regulating HNRNPA1-related RNA splicing[J]. The Journal of Biomedical Research, 2024, 38(4): 358-368. DOI: 10.7555/JBR.38.20240030
    [2]Lulu Fan, Hao Wang, Shuai Ben, Yifei Cheng, Silu Chen, Zhutao Ding, Lingyan Zhao, Shuwei Li, Meilin Wang, Gong Cheng. Genetic variant in a BaP-activated super-enhancer increases prostate cancer risk by promoting AhR-mediated FAM227A expression[J]. The Journal of Biomedical Research, 2024, 38(2): 149-162. DOI: 10.7555/JBR.37.20230049
    [3]Li Xin, Yang Jian, Chen Xia, Cao Dandan, Xu Eugene Yujun. PUM1 represses CDKN1B translation and contributes to prostate cancer progression[J]. The Journal of Biomedical Research, 2021, 35(5): 371-382. DOI: 10.7555/JBR.35.20210067
    [4]Du Haina, Song Guoxin, Fang Mingzhi, Shu Yongqian, Zhao Xin, Zhu Lingjun. A meta-analysis of caspase-8 -652 6N del polymorphism and digestive tract cancer risk[J]. The Journal of Biomedical Research, 2019, 33(3): 173-180. DOI: 10.7555/JBR.32.20160030
    [5]Il-Seok Lee, Sung Pil Seo, Yun Sok Ha, Pildu Jeong, Ho Won Kang, Won Tae Kim, YongJune Kim, Seok Joong Yun, Sang Cheol Lee, Wun-Jae Kim. Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer[J]. The Journal of Biomedical Research, 2017, 31(3): 226-231. DOI: 10.7555/JBR.31.20160072
    [6]Marwan Ghosn, Alain Dagher, Fadi El-Karak. Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer patient[J]. The Journal of Biomedical Research, 2015, 29(5): 420-422. DOI: 10.7555/JBR.28.20130148
    [7]William Weiben Zhang, Zhenqing Feng, Steven A Narod. Multiple therapeutic and preventive effects of 3,39-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia[J]. The Journal of Biomedical Research, 2014, 28(5): 339-348. DOI: 10.7555/JBR.28.20140008
    [8]Lifeng Zhang, Ning Shao, Qianqian Yu, Lixin Hua, Yuanyuan Mi, Ninghan Feng. Association between p53 Pro72Arg polymorphism and prostate cancer risk: a meta-analysis[J]. The Journal of Biomedical Research, 2011, 25(1): 25-32. DOI: 10.1016/S1674-8301(11)60003-1
    [9]Yuanyuan Mi, Qianqian Yu, Zhichao Min, Bin Xu, Lifeng Zhang, Wei Zhang, Ninghan Feng, Lixin Hua. Arg462Gln and Asp541Glu polymorphisms in ribonuclease L and prostate cancer risk: a meta-analysis[J]. The Journal of Biomedical Research, 2010, 24(5): 365-373. DOI: 10.1016/S1674-8301(10)60049-8
    [10]Bingbing Wei, Yunyun Zhang, Bo Xi, Junkai Chang, Jinming Bai, Jiantang Su. CYP17 T27C polymorphism and prostate cancer risk:a meta-analysis based on 31 studies[J]. The Journal of Biomedical Research, 2010, 24(3): 233-241.

Catalog

    Article Metrics

    Article views (3867) PDF downloads (1270) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return